Abstract: A method for preparing a polyolefin resin powder has the steps of a) heat dissolving a polyolefin resin in an organic solvent having a solubility parameter less than or equal to the solubility parameter of the polyolefin resin to obtain a polyolefin resin solution; b) cooling the polyolefin resin solution to precipitate a solid, thereby obtaining a solid-liquid mixture; c) optionally adding an adjuvant to the solid-liquid mixture and mixing; and d) conducting solid-liquid separation and drying to obtain a polyolefin resin powder suitable for selective laser sintering. The difference between the solubility parameters of the organic solvent and of the polyolefin resin is within 0-20% of the solubility parameter of the polyolefin resin. The polyolefin resin powder obtained according to this method has good antioxidant property, good powder flowability, moderate size, smooth surface, suitable bulk density, and suitable dispersibility and particle size distribution.

Abstract: A method for preparing an aliphatic polyester resin powder includes the steps of a) heat dissolving a crystalline aliphatic polyester resin in an organic solvent to obtain an aliphatic polyester resin solution; b) cooling the aliphatic polyester resin solution to precipitate a solid, thereby obtaining a solid-liquid mixture; c) optionally adding an adjuvant to the solid-liquid mixture and mixing; and d) conducting solid-liquid separation and drying to obtain an aliphatic polyester resin powder suitable for selective laser sintering. The crystalline aliphatic polyester resin powder obtained has good antioxidant property, good powder flowability, moderate size, smooth surface, suitable bulk density, and suitable dispersibility and particle size distribution. The aliphatic polyester resin powder is particularly suitable for selective laser sintering method.

Abstract: The present application relates to a system and a method for handling a fault of an aircraft. The system for handing a fault of an aircraft comprises an interface module for receiving the fault message and a troubleshooting decision-making unit for making a troubleshooting decision against the aircraft faults, wherein the troubleshooting decision is made by the troubleshooting decision-making unit based on fault types/safety risks and cost estimation. The examples in the application allow a cost-effective troubleshooting decision.

Abstract: A polyethylene composition comprising an ethylene/?-olefin copolymerized linear low density polyethylene, wherein the polyethylene composition has a Mw of from 100,000 g/mol to 200,000 g/mol, a Mw/Mn of from 4.0 to 9.0, a Mz/Mw of from 4.0 to 7.0, and a Mz+1/Mw of from 4.5 to 13.5, is provided. A film formed of the polyethylene composition is also provided.

Abstract: The invention relates to a flame-retardant thermoplastic material, comprising thermoplastic base resin, a flame retardant, and an optional antioxidant, wherein the flame retardant comprises a complex of phosphine oxide and a transition metal salt. The invention also relates to flame-retardant thermoplastic expanded beads. A foam molding prepared from the flame-retardant thermoplastic expanded beads has good flame-retardant and antistatic properties, has excellent mechanical properties and is widely used.

Abstract: The present invention refers to a flame retardant comprising a complex formed by phosphine oxide and transition metal salt, wherein has good flame retardant property. The present invention also refers to a composite flame retardant and flame retardant antistatic composition, wherein composite flame retardant comprise the flame retardant and the inorganic flame retardant component as described above, which has an enhanced flame retardant effect; said flame retardant antistatic composition, comprising above described flame retardant or composite flame retardant and carbon nanofiber antistatic agent, wherein carbon nanofiber antistatic agent could have interaction with flame retardant, effectively reducing the amount of flame retardant, and the combination with the flame retardant without the adverse effect of each other which result in negative performance of each other, does not influence the subsequent foaming process and the foam structure and physical properties.

Abstract: Hybrid compounds of curcumin and melatonin as neuroprotectants are provided. The hybrid compounds are useful for the treatment and/or prevention of Alzheimer's disease (AD), as well as other neurodegenerative diseases. The hybrid compounds exhibited superior and potent neuroprotection in an AD model.

Abstract: The invention belongs to the field of biomass energy utilization, and a continuous pyrolysis and carbonization method of agricultural and forestry biomass is disclosed. The method comprises the following steps: feeding biomass feedstock to a dryer for drying, then transporting to a continuous pyrolysis apparatus for pyrolyzing to obtain pyrolysis semicoke and pyrolysis volatiles; and transporting the pyrolysis semicoke to a carbonization apparatus for carbonization to obtain biomass charcoal and semi-coke carbonized volatiles; then discharging the pyrolysis volatiles and the semi-coke carbonized volatiles, and cooling to obtain tar, wood vinegar and pyrolysis gas; introducing the pyrolysis gas into a combustion apparatus for combustion to obtain a high temperature flue gas; and finally transporting the high temperature flue gas into pyrolysis apparatus and carbonization apparatus for supplying heat, then the flue gas after supplying heat is delivered to the dryer and discharging tail gas.

Abstract: 3-(2-amino-ethyl)-5-[3-(4-substituted-phenyl)-alkylidene)-thiazolidine-2,4-dione and 1-(2-amino-ethyl)-3-alkylidene-1,3-dihydro-indol-2-one and derivatives thereof are provided for use as selective SphK2 inhibitors and for use in the treatment of human diseases, such as cancer.

Abstract: Hybrid compounds of curcumin and melatonin as neuroprotectants are provided. The hybrid compounds are useful for the treatment and/or prevention of Alzheimer's disease (AD), as well as other neurodegenerative diseases. The hybrid compounds exhibited superior and potent neuroprotection in an AD model.

Abstract: 3-(2-amino-ethyl)-5-[3-(4-substituted-phenyl)-alkylidene)-thiazolidine-2,4-dione and 1-(2-amino-ethyl)-3-alkylidene-1,3-dihydro-indol-2-one and derivatives thereof are provided for use as selective SphK2 inhibitors and for use in the treatment of human diseases, such as cancer.

Abstract: A polyethylene composition comprising an ethylene/?-olefin copolymerized linear low density polyethylene, wherein the polyethylene composition has a Mw of from 100,000 g/mol to 200,000 g/mol, a Mw/Mn of from 4.0 to 9.0, a Mz/Mw of from 4.0 to 7.0, and a Mz+1/Mw of from 4.5 to 13.5, is provided. A film formed of the polyethylene composition is also provided.

Abstract: Inhibitors that are anti-inflammatory agents are provided, as are methods of using the analogs to inhibit inflammation and prevent or treat diseases and conditions associated with inflammation, such as heart failure and autoimmune diseases.

Abstract: A toughened plastic and its preparation method, with the toughened plastic being obtained by rubber-plastic blending of brittle or less brittle plastics and a rubber mixture. The rubber mixture consists of powdery rubbers having a cross-linked structure and an average particle size of not more than 0.50 ?m, and at least one selected from the group consisting of unvulcanized rubbers and thermoplastic elastomers. The morphology and the particle size distribution of the rubber phase contained in the toughened plastic can be controlled by changing the particle size of the powdery rubbers having a cross-linking structure and choosing proper unvulcanized rubbers or thermoplastic elastomers. The toughened plastic has good toughness and processability while keeping better strength and stiffness.

Abstract: The invention discloses a process for preparing high-performance propylene polymers, the process utilizing a high activity, highly stereoselective Ziegler-Natta catalyst and two or more stages of polymerization carried out under different hydrogen concentrations to prepare propylene polymers having broad molecular weight distribution, wherein non-uniformness of isotacticity of molecular chains of the final propylene polymers is improved by adjusting or controlling stereoselectivity of catalytic active sites under different hydrogen concentrations, namely, making the low molecular weight fraction of the polymers having a higher isotacticity and making the high molecular weight fraction of the polymers having a lower isotacticity, thereby overcoming the drawbacks of the propylene polymers having broad molecular weight distribution known in the art. The resulting final polymers have excellent combined properties, in particular, remarkably improved mechanical properties.

Abstract: The present invention provides a process for preparing high melt strength propylene polymer by direct polymerization, comprising that a propylene polymer with wide molecular weight distribution and containing “very high molecular weight fraction” can be prepared by controlling the species and ratios of the external electron donors in the Ziegler-Natta catalyst system at different reaction stages according to the requirement for different molecular weight fractions in the different propylene polymerization stage of the series operation, and said polymer has excellent mechanical properties, especially with very high melt strength. The present invention also provides a propylene homopolymer with high melt strength, comprising the following features: (1) the MFR is 0.2-10 g/10 min at 230° C. with a load of 2.16 kg; (2) the molecular weight distribution Mw/Mn is 6-20; (3) the content of the fraction with a molecular weight higher than 5,000,000 is higher than or equal to 0.

Abstract: The present invention relates to a sodium glucose cotransporter 2 (SGLT2) inhibitor with a phenyl C-glucoside structure, its preparation method, a pharmaceutical composition containing the same, and its use in treating diabetes and preparing an anti-diabetes medicament. The invention provides a compound with the structure of general formula I and a pharmaceutically acceptable salt and prodrug ester thereof, wherein, the definitions of R5 and R6 are selected from the following: (1) R5=R6=Me; (2) R5=Me, R6=OMe; (3) R5=Me, R6=H; (4) R5=Me, R6=F; (5) R5=F, R6=H; and (6) R5=OMe, R6=H.

Abstract: 3-(2-amino-ethyl)-5-[3-(4-substituted-phenyl)-alkylidene)-thiazolidine-2,4-dione and 1-(2-amino-ethyl)-3-alkylidene-1,3-dihydro-indol-2-one and derivatives thereof are provided for use as selective SphK2 inhibitors and for use in the treatment of human diseases, such as cancer.

Abstract: This invention provides a method for preparing cycloastragenol monoglucoside CMG (cycloastragenol-6-O-?-D-glucoside), comprising the steps of: a. using astragaloside IV or Astragali extracts prepared by a conventional method as raw materials and adding an appropriate solvent thereinto to form a raw material solution; b. adding hydrolase and allowing for hydrolysis at a constant temperature to obtain a hydrolysate; c. separating the hydrolysate with macroporous adsorption resin; and d. obtaining the product by purification and separation. The present invention further provides cycloastragenol-6-O-?-D-glucoside prepared according to the method of this invention as well as its use in the preparation of a medicament for treating cardiovascular diseases and pharmaceutical compositions comprising the same.

Abstract: Disclosed herein are a polypropylene with narrow molecular weight distribution and a process for preparing the same in a reactor using a Ziegler-Natta catalyst.